|1.||Cano, C: 2 articles (09/2015 - 07/2015)|
|2.||Marín, C: 2 articles (09/2015 - 07/2015)|
|3.||Sanz, A M: 2 articles (09/2015 - 07/2015)|
|4.||Campayo, L: 2 articles (09/2015 - 07/2015)|
|5.||Gómez-Contreras, F: 2 articles (09/2015 - 07/2015)|
|6.||Navarro, P: 2 articles (09/2015 - 07/2015)|
|7.||Sánchez-Moreno, M: 2 articles (09/2015 - 07/2015)|
|8.||Ramírez-Macías, I: 2 articles (09/2015 - 07/2015)|
|9.||Rosales, M J: 2 articles (09/2015 - 07/2015)|
|10.||Yunta, M J R: 2 articles (09/2015 - 07/2015)|
03/01/2010 - "Evaluation of the anticonvulsant activity of 6-(4-chlorophenyoxy)-tetrazolo[5,1-a]phthalazine in various experimental seizure models in mice."
03/01/2010 - "This study investigated the anticonvulsant activity of a new phthalazine tetrazole derivative, QUAN-0808 (6-(4-chlorophenoxy)-tetrazolo[5,1-a]phthalazine), in the mouse maximal electroshock (MES) seizure model. "
|2.||Hypertension (High Blood Pressure)
01/01/1981 - "[Phthalazine derivatives in the treatment of arterial hypertension]."
05/13/1957 - "[Result of the treatment of hypertension with carbo-ethoxy hydrazino phthalazine hydrochloride]."
07/14/1955 - "[Use of phthalazine derivatives in arterial hypertension]."
02/01/1958 - "[Effects of digestive activities on blood pressure regulation in hypertension under the effects of reserpine and phthalazine bodies]."
05/01/1957 - "[Combined reserpine-phthalazine in arterial hypertension; results]."
01/01/2012 - "We also identified a competitive antagonist of the interaction of anandamide with FLAT, the phthalazine derivative ARN272, that prevented anandamide internalization in vitro, interrupted anandamide deactivation in vivo and exerted profound analgesic effects in rodent models of nociceptive and inflammatory pain, which were mediated by CB(1) cannabinoid receptors. "
02/10/2005 - "Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties."
10/01/2010 - "A novel spleen tyrosine kinase (SYK) P-site inhibitor, 1,4-Bis (9-O dihydroquinidinyl) phthalazine/hydroquinidine 1,4-phathalazinediyl diether (C-61), (but not vehicle) markedly enhanced H(2)O(2)-induced apoptosis of primary leukemia cells from each of five relapsed B-lineage acute lymphoblastic leukemia (ALL) patients, as measured by in vitro TUNEL assays. "
07/05/1994 - "The action of two structurally related DNA intercalating agents has been studied and compared, namely 4'-(9-acridinylamino) methanesulphon-m-anisidide (amsacrine, mAMSA) and 1,4-bis(butylamino)benzo[g]phthalazine (ABP) on the cell cycle and differentiation of U-937 human promonocytic leukemia cells. "
07/01/2015 - "Imidazole-containing phthalazine derivatives inhibit Fe-SOD performance in Leishmania species and are active in vitro against visceral and mucosal leishmaniasis."
09/01/2015 - "Imidazole-containing phthalazine derivatives inhibit Fe-SOD performance in Leishmania species and are active in vitro against visceral and mucosal leishmaniasis--CORRIGENDUM."
|1.||6- (4- chlorophenoxy)tetrazolo(5,1- a)phthalazine
|5.||Cannabinoid Receptors (Cannabinoid Receptor)
|9.||DNA (Deoxyribonucleic Acid)